Patterns and trends in esophageal cancer incidence and mortality in China:An analysis based on cancer registry data

Background:Esophageal cancer poses a significant global burden,while its patterns and trends remain to be clarified.The aim of this study is to provide an update on the incidence and mortality rates of esophageal cancer and their trends in China based on data from the National Cancer Registry.Methods:We extracted data from the National Central Cancer Registry(NCCR)of China from 2000 to 2016 and performed comprehensive quality control.We calculated age-standardized rates of China(ASR China)and world(ASR world)using the Chinese population in 2000 and the Segi’s world standard population,and performed a joinpoint regression analysis to examine the trend in incidence and mortality of esophageal cancer.The annual percent change(APC)and weighted average APC(AAPC)over the entire study period were estimated to measure the changing trend.Subgroup analyses were conducted by sex,region and pathological type.Results:A total of 487 eligible cancer registries were included in the data analysis and 22 registries with unin-terrupted registration data were used for trend analysis.In 2016,there were an estimated of 184,500 incident cases of esophageal cancer and 142,300 deaths in China.The crude incidence,ASR China and ASR world were 25.25/100,000,11.00/100,000 and 11.13/100,000,respectively.And the crude mortality,ASR China and ASR world were 19.38/100,000,8.25/100,000 and 8.28/100,000,respectively.Esophageal squamous cell carcinoma(ESCC)was the most common histological type,accounting for 85.79%of all cases,followed by esophageal ade-nocarcinoma(EAC)(11.00%)and others(3.21%).There was a decreasing trend of ASR world in incidence and mortality during 2000-2016 with the AAPC of-4.6%(95%CI:-5.7%,-3.4%)and-4.6%(95%CI:-5.2%,-3.9%).The pattern and trend of esophageal cancer differ in sex,region and pathological type.Conclusions:The burden of esophageal cancer in China remains high with sex,regional and subtype differences.The incidence and mortality of esophageal cancer have continued to decline over the past decade,which was due in part to the reductions in risk factor exposure and the implementation of screening.

Cancer incidence and mortality in China,2022

Background:The National Cancer Center(NCC)of China regularly reports the nationwide statistics on cancer incidence and mortality in China.The International Agency for Research on Cancer(IARC)calculates and publishes the cancer burden of countries around the world every two years.To ensure consistency between the actual surveillance data in China and the data published by IARC,NCC has received approval from the National Health Commission and IARC to simultaneously release the cancer burden data for China in GLOBOCAN 2022.Methods:There were a total of 700 registries reporting high-quality data on cancer incidence and mortality across China in 2018,of which 106 registries with continuous monitoring from 2010 to 2018 were used to establish an age-period-cohort model to simulate the trend of cancer incidence and mortality and to estimate the incidence and mortality in China in 2022.In addition,we analyzed the temporal trends of age-standardized cancer incidence and mortality from 2000 to 2018 using data from 22 continuous cancer registries.Results:It was estimated about 4,824,700 new cancer cases and 2,574,200 new cancer deaths occurred in China in 2022.Cancers of the lung,colon-rectum,thyroid,liver and stomach were the top five cancer types,accounting for 57.42%of new cancer cases.Cancers of the lung,liver,stomach,colon-rectum and esophagus were the five leading causes of cancer deaths,accounting for 67.50%of total cancer deaths.The crude rate and age-standardized incidence rate(ASIR)were 341.75 per 100,000 and 201.61 per 100,000,respectively.The crude mortality rate was 182.34 per 100,000 and the age-standardized mortality rate(ASMR)was 96.47 per 100,000.The ASIR of all cancers combined increased by approximately 1.4%per year during 2000–2018,while the ASMR decreased by approximately 1.3%per year.We observed decreasing trends in ASIR and ASMR for cancers of the esophagus,stomach,and liver,whereas the ASIR increased significantly for cancers of the thyroid,prostate,and cervix.Conclusions:Cancer remains a major public health concern in China,with a cancer profile that reflects the coexistence of developed and developing regions.Sustained implementation of prevention and control measures has resulted in significant reductions in the incidence and mortality rates of certain historically high incidence cancers,such as esophageal,stomach and liver cancers.Adherence to the guidelines of the Healthy China Action Plan and the Cancer Prevention and Control Action Plan,along with continued efforts in comprehensive risk factor control,cancer screening,early diagnosis and treatment,and standardization of diagnostic and therapeutic protocols,are key strategies to effectively mitigate the increasing cancer burden by 2030.

Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal,stomach and liver cancer in China,2010-2016

Background:A population-based cancer screening program in rural China,targeting three types of cancer that are most prevalent in these areas,including esophageal,stomach,and liver cancer was awarded by the government in China since 2007.A two-step design with cancer risk assessment based on questionnaire interview and HBsAg test strip and subsequent clinical intervention for high-risk populations was adopted with free of charge at the local hospitals designated in the program.The participate rate including high-risk rates and screening rates was important to find appropriate strategies to improve the overall awareness of the program.Methods:Data from the cancer screening program between 2010 and 2016 were used to calculate higher rate(high-risk population/participants recruited)and screening rate(participants received screening/high-risk pop-ulation).Results:From 2010 to 2016,1,637,429 residents were recruited in the program and filled the questionnaires,350,646(21.4%)for esophagus cancer,273,715(16.7%)for stomach cancer and 1,013,068(61.9%)for liver can-cer.471,974 participants were assessed as high-risk population including 114,786(24.3%)high risk for esophagus cancer,161,809(34.3%)high risk for stomach cancer and 195,379(41.4%)high risk for liver cancer,respec-tively.249,185(52.8%)participants who were assessed as high risk received clinical screening.There were 64,710(26.0%)for esophagus cancer screening,71,365(28.6%)for stomach cancer screening and 113,110(45.4%)for liver cancer screening,respectively.Conclusion:Our findings will provide important references for designing effective population-based screening strategies to enhance the screening acceptance by health action plan in the future.

The burden and long-term trends of breast cancer by different menopausal status in China

Background: The burden of breast cancer in women of different menopausal status has not been assessed in China previously. We aim to evaluate and project the burden of breast cancer in different menopausal status in China. Methods: The incidence and mortality of breast cancer were estimated using the data of 554 cancer registries in 2017 and the trends of incidence and mortality of 112 cancer registries from 2010 to 2017. Data from 22 continued cancer registries from 2000 to 2017 were applied for long-term trend projection to 2030 using the Bayesian age- period-cohort model. Menopausal status was stratified by age, with premenopause defined as chronological age < 45 years, perimenopause defined as 45-54 years, and postmenopause defined as ≥ 55 years. Results: Approximately 352,300 incident cases and 74,200 deaths of breast cancer occurred in China in 2020, contributing to 2.6 million disability-adjusted life years (DALYs). Perimenopausal women had the highest inci- dence, prevalence, and DALYs rates, with the rates being 100.3 per 100,000, 819.2 per 100,000 and 723.1 per 100,000 persons. While postmenopausal women had the highest mortality rates (25.5 per 100,000 persons). From 2000 to 2017, the largest increase in incidence and mortality for breast cancer was observed in postmenopausal women with an average annual percentage change (AAPC) of 5.6% and 2.94%. The number of breast cancer cases and deaths will increase to 452,000 and 98,800 in 2030, resulting in 3.2 million DALYs. Conclusions: The burden of breast cancer is rapidly increasing in China and varies among different menopausal status. Specific prevention and control strategies for women in different menopausal status will be more helpful in reducing the rapidly growing trends of breast cancer.

Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030

Objective:Breast cancer was the most common cancer and the fifth cause of cancer deaths among women in China in 2015.The evaluation of the long-term incidence and mortality trends and the prediction of the future burden of breast cancer could provide valuable information for developing prevention and control strategies.Methods:The burden of breast cancer in China in 2015 was estimated by using qualified data from 368 cancer registries from the National Central Cancer Registry.Incident cases and deaths in 22 cancer registries were used to assess the time trends from 2000 to 2015.A Bayesian age-period-cohort model was used to project the burden of breast cancer to 2030.Results:Approximately 303,600 new cases of breast cancer(205,100 from urban areas and 98,500 from rural areas)and 70,400 breast cancer deaths(45,100 from urban areas and 24,500 from rural areas)occurred in China in 2015.Urban regions of China had the highest incidence and mortality rates.The most common histological subtype of breast cancer was invasive ductal carcinoma,followed by invasive lobular carcinoma.The age-standardized incidence and mortality rates increased by 3.3%and 1.0%per year during 2000–2015,and were projected to increase by more than 11%until 2030.Changes in risk and demographic factors between 2015 and 2030 in cases are predicted to increase by approximately 13.3%and 22.9%,whereas deaths are predicted to increase by 13.1%and 40.9%,respectively.Conclusions:The incidence and mortality of breast cancer continue to increase in China.There are no signs that this trend will stop by 2030,particularly in rural areas.Effective breast cancer prevention strategies are therefore urgently needed in China.

Liver cancer incidence and mortality in China: Temporal trends and projections to 2030

Objective: Liver cancer is one of the most common cancers and major cause of cancer deaths in China,which accounts for over 50% of new cases and deaths worldwide.The systematic liver cancer statistics including of projection through 2030 could provide valuable information for prevention and control strategies in China,and experience for other countries.Methods: The burden of liver cancer in China in 2014 was estimated using 339 cancer registries’ data selected from Chinese National Cancer Center(NCC).Incident cases of 22 cancer registries were applied for temporal trends from 2000 to 2014.The burden of liver cancer through 2030 was projected using age-period-cohort model.Results: About 364,800 new cases of liver cancer(268,900 males and 95,900 females) occurred in China,and about 318,800 liver cancer deaths(233,500 males and 85,300 females) in 2014.Western regions of China had the highest incidence and mortality rates.Incidence and mortality rates decreased by about 2.3% and 2.6% per year during the period of 2000-2014,respectively,and would decrease by more than 44% between 2014 and 2030 in China.The young generation,particularly for those aged under 40 years,showed a faster down trend.Conclusions: Based on the analysis,incidence and mortality rates of liver cancer are expected to decrease through 2030,but the burden of liver cancer is still serious in China,especially in rural and western areas.Most cases of liver cancer in China can be prevented through vaccination and more prevention efforts should be focused on high risk groups.

The epidemiology of colorectal cancer in China

Objective:Colorectal cancer(CRC)is one of the most common cancers and the major cause of cancer death in China.The aim of this study was to estimate the burden of CRC in China.Materials and methods:Data from the National Cancer Center(NCC)of China was used and stratified by area(urban/rural),sex(male/female)for analyzing the age-speci c incidence and mortality rates.Time trend of colorectal cancer was calculated based on the 22 high-quality cancer registries in China.National new cases and deaths of colorectal cancer were estimated using age-speci c rates multiplied by the corresponding national population in 2014.The Chinese population in 2000 and Segi’s world population were used to calculate age-standardized rates of colorectal cancer in China.Results:Overall,370,400 new colorectal cancer cases and 179,600 deaths were estimated in China in 2014,with about 214,100 new cases in men and 156,300 in women.Meanwhile,104,000 deaths cases of colorectal cancer were men and 75,600 deaths were women,which accounted for 9.74%and 7.82%of all cancer incidence and deaths in China,separately.Relatively higher incidence and mortality was observed in urban areas of China.And the Eastern areas of China showed the highest incidence and mortality.The age-standardized incidence and mortality rate of colorectal cancer has increased by about 1.9%per year for incidence and about 0.9%per year for mortality rate from 2000 to 2014.Conclusion:With gradually higher incidence and mortality rate in the past 15 years,colorectal cancer became a major challenge to China’s public health.E ective control strategies are needed in China.

Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea

Objective： In patients with chemotherapy-induced amenorrhea （CIA）, the menopausal status is ambiguous anddifficult to evaluate. This study aimed to establish a discriminative model to predict and classify the menopausalstatus of breast cancer patients with CIA.Methods： This is a single center hospital-based study from 2013 to 2016. The menopausal age distribution andaccumulated incidence rate of CIA are described. Multivariate models were adjusted for established and potentialconfounding factors including age, serum concentration of estradiol （E2） and follicle-stimulating hormone （FSH）,feeding, pregnancy, parity, abortions, and body mass index （BMI）. The odds ratio （OR） and 95% confidenceinterval （95% CI） of different risk factors were estimated.Results： A total of 1,796 breast cancer patients were included in this study, among whom, 1,175 （65.42%） werepremenopausal patients and 621 （34.58%） were post-menopause patients. Five hundred and fifty patients wereincluded in CIA analysis, and a cumulative CIA rate of 81.64% was found in them. Age （OR： 1.856, 95% CI：1.732-1.990）, serum concentration of E2 （OR： 0.976, 95% CI： 0.972-0.980） and FSH （OR： 1.060, 95% CI：1.053-i.066）, and menarche age （OR： 1.074, 95% CI： 1.009-1.144） were found to be associated with the patients＇menopausal status. According to multivariate analysis, the discriminative model to predict the menopausal status isLogit （P）=-28.396＋0.536Age-0.014E2＋0.031FSH. The sensitivities for this model were higher than 85%, and itsspecificities were higher than 89%.Conclusions： The discriminative model obtained from this study for predicting menstrual state is important forpremenopausal patients with CIA. This model has high specificity and sensitivity and should be prudently used.

Cancer incidence and mortality in China,2016

Background:National Cancer Center(NCC)of China annually reports the nationwide statistics for cancer inci-dence and mortality using population-based cancer registry data from all available cancer registries in China.Methods:There were a total of 487 registries which reported high quality data of cancer incidence and mortality across China in 2016.The nationwide numbers of new cancer cases and deaths were estimated using the pooled cancer registry data,which were stratified by area(urban/rural),sex,age group(0,1-4,5-9,10-14…85+)and cancer site for incidence and mortality,and then multiplied by corresponding national population.The world Segi’s population was applied for the calculation of age-standardized rates.Results:About 4,064,000 new cancer cases and 2,413,500 new cancer deaths occurred in China in 2016.Cancers of the lung,colon-rectum,stomach,liver and female breast were the top five common cancers,accounting for 57.4%of total cancer new cases.Cancers of the lung,liver,stomach,colon-rectum and esophagus were the five leading causes of cancer deaths,accounting for 69.3%of total cancer deaths.The crude and age-standardized incidence rates(ASIR)were 293.91 and 186.46 per 100,000 population,respectively.The crude mortality rate was 174.55/100,000 and the age-standardized mortality rate(ASMR)was 105.19/100,000.The ASIR was higher but the ASMR was lower in urban areas than that in rural areas.In past decades,the ASIR was relatively stable in males,but significantly increased by about 2.3%per year in females for overall cancers combined.In contrast,the ASMR significantly decreased by about 1.2%per year for both sexes during 2000-2016.Notably,the cancer-specific ASIR and ASMR of esophageal,stomach,and liver cancers decreased significantly,whereas both rates for cancers of the colon-rectum,prostate,female breast,cervix,and thyroid increased significantly.Conclusions:Cancer remains a major public health problem in China,which demands long-term collaborative efforts of a broad community.With the national guideline on cancer prevention and control,tailored cancer prevention and control programs are needed in different regions to help reduce the burden of these highly fatal diseases in China.

Cancer incidence and mortality in China,2015

Background:National Cancer Center(NCC)updated nationwide cancer statistics using population-based cancer registry data in 2015.Methods:501 cancer registries submitted data,among which 368 registries with high quality data were included in analysis.Numbers of nationwide new cancer cases and deaths were estimated using incidence and mortality rates and corresponding national population stratified by area,sex,age group and cancer site.The world Segi’s population was applied for the calculation of age-standardized rates.Results:About 3,929,000 new cancer cases were diagnosed.The crude incidence rate was 285.83/100,000 and the age-standardized incidence rate by world standard population(ASIRW)was 186.39/100,000.ASIRW was higher in urban areas than in rural areas.South China had the highest ASIRW while Southwest China had the lowest ASIRW.Age-specific incidence rate was higher in males for population younger than 20 years or over 49 years.From 2000 to 2015,the ASIRWs for esophageal cancer,gastric cancer and liver cancer decreased significantly.The ASIRWs for colorectal cancer in whole population and for lung cancer,breast cancer,cervix cancer,uterus cancer and thyroid cancer in females increased significantly.2,338,000 cancer deaths were reported.The crude mortality rate was 170.05/100,000 and the age standardized mortality rate by world standard population(ASMRW)was 105.84/100,000.ASMRW was higher in rural areas than in urban areas.Central China had the highest ASMRW while North China had the lowest ASMRW.Age-specific mortality rates in males were higher than that in females in every age group.From 2000 to 2015,the ASMRWs for esophageal cancer,gastric cancer,liver cancer and lung cancer decreased significantly.The ASMRWs for colorectal cancer,pancreas cancer and prostate cancer in males and for breast cancer,cervix cancer and thyroid cancer in females increased significantly.Conclusions:Cancer has become a major life-threatening disease in China.Disease burdens differed across areas.Disease burdens for esophageal cancer,gastric cancer and liver cancer have decreased,while disease burdens for colorectal cancer,female breast cancer,cervix cancer and thyroid cancer have increased over the last 15 years.National and regional initiative for cancer prevention and control should be prioritized.

Lung cancer incidence and mortality in China:Updated statistics and an overview of temporal trends from 2000 to 2016

Background:Updated systematic statistics on lung cancer are the underpinning cornerstones for formulating prevention and control strategies for the disease.The incidence and mortality data of lung cancer in China in 2016 were estimated,and also used to analyze the temporal trends of lung cancer from 2000 up to 2016 in this study.Methods:The burden of lung cancer in China in 2016 was estimated using data from 487 cancer registries,which were abstracted from the database of the National Cancer Center of China(NCC).The temporal trends were estimated with the data of 2000 to 2016 from 22 cancer registries.Results:About 828,100 new lung cancer cases and 657,000 lung cancer deaths were estimated in China in 2016.The crude incidence and mortality rates in the eastern region were the highest nationwide.The incidence and mortality of lung cancer increased with age,and most of the new cases occurred in the age group of over 60 years.The age-standardized incidence increased by about 0.8%per year during 2000 to 2016,especially in woman,whose annual increase rate reached 2.1%.The age-standardized mortality rate decreased by about 0.6%per year,with a decrease of 1.3%per year in urban areas and an increase of 2.3%per year in rural areas.The numbers of new cases and deaths increased by 162.6%and 123.6%,respectively,during 2000 to 2016,which can be explained mainly by the change of the age structure.Conclusions:The burden of lung cancer is serious in China,and increased especially rapidly for women in rural areas.The disease is expected to threaten the lives of more people in the future due to factors such as aging and population growth.Lung cancer prevention and control strategies and resources should be leveraged toward women and rural areas in the future.

Incidence and mortality of cervical cancer in China in 2015

Objective:To estimate the incidence and mortality of cervical cancer in China based on the cancer registration data in 2015,collected by the National Central Cancer Registry(NCCR).Methods:There were 501 cancer registries that submitted data to the NCCR,whose data were the basis for estimating the incidence and mortality of cervical cancer in China in 2015.After evaluating the data quality,368 registries’data were accepted for the analysis and stratified by area(urban/rural)and age group.Combined with data on the national population in 2015,the nationwide incidence and mortality of cervical cancer were estimated.Cervical Cancer cases of 22 cancer registries were applied for temporal trends from 2000 to 2015.The Chinese population census in 2000 and Segi’s population were used to calculate age-standardized incidence and mortality rates.Results:An estimated 111,000 new cases were attributed to cervical cancer in China in 2015,accounting for 6.24%of all female new cancer cases in that year in China.The crude rate(CR)of incidence and age-standardized incidence rates by the China standard population(ASIRC)and by Segi’s world standard population(ASIRW)of cervical cancer were 16.56/100,000,11.78/100,000,and 10.86/100,000,respectively.The cumulative incidence rate from birth to 74 years old was 1.15%,whereas the calculation of incidence rates over the truncated age range of 35-64 years by Segi’s world standard population(T-ASIRW)was 27.66/100,000.The estimates of cervical cancer deaths were about 33,800 and 3.94%of all female cancer-related deaths in China in 2015,with a crude mortality rate of 5.04/100,000.The age-standardized mortality rates adjusted by the Chinese standard population(ASMRC)and by world Segi’s population(ASMRW)were 3.29/100,000 and 3.15/100,000,respectively,with a cumulative mortality rate(0-74 years old)of 0.35%.Both the incidence and mortality were higher in rural than in urban areas.The age-specific cervical cancer incidence significantly increased with age,particularly after age 25 years,and peaked at 50-54 years old,whereas age-specific mortality increased rapidly after 35 years old,peaking at 80-84 years old.The age-standardized incidence rates increased by about 8.6(95%CI:6.9,10.3)per year during the period of 2000−2015.The age at diagnosis of patients with cervical cancer tended to be younger.In rural areas,the mean age at diagnosis decreased about 3.22 years from 2000 to 2015(𝛽=-0.33,P<0.001).Conclusions:China has a high burden of cervical cancer and important disparities among different regions.Es-pecially in the middle and western areas and rural areas,cervical cancer is a serious issue in women’s health,and prevention strategies need to be enhanced.Prevention and control strategies need to be enhanced and imple-mented with reference to local status,such as human papillomavirus(HPV)vaccination and screening programs.

Global patterns of breast cancer incidence and mortality:A population-based cancer registry data analysis from 2000 to 2020

Background:Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different countries.This study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and control.Methods:Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online database.Continued data from the Cancer Incidence in Five Continents Time Trends,the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression,and annual average percent changes of breast cancer incidence and mortality were calculated.Association between Human Development Index and breast cancer incidence and mortality were estimated by linear regression.Results:There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in 2020.Its incidence and mortality varied among countries,with the age-standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran,and the age-standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South Korea.The peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American countries.As for the trends of breast cancer,the age-standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America(USA)during 2000-2012.Meanwhile,the age-standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom,the USA,and Australia during 2000 and 2015.Conclusions:The global burden of breast cancer is rising fast and varies greatly among countries.The incidence and mortality rates of breast cancer increased rapidly in China and South Korea but decreased in the USA.Increased health awareness,effective prevention strategies,and improved access to medical treatment are extremely important to curb the snowballing breast cancer burden,especially in the most affected countries.

Cancer statistics in Chinese older people,2022:current burden,time trends,and comparisons with the US,Japan,and the Republic of Korea

Largely due to population ageing,the cancer burden from older people has been rising,which imposed considerable pressure on current Chinese healthcare system.We provide comprehensive information about cancer burden of Chinese older people based on the most recent data from National Central Cancer Registry of China.The logarithmic linear regression was used to project the current cancer burden in 2022,and Joinpoint regression was used for temporal trend analysis from 2000 to 2017.We also estimated cancer statistics of older people in the US,Japan and the Republic of Korea for comparisons.It is estimated that 2.79 million cases and 1.94 million deaths occur for Chinese older people,representing 55.8%and 68.2%of cases and deaths in all population in 2022.The overall cancer incidence rate gradually increased among older women,while the mortality rates declined for both sexes.Notably,approximately 10.0%of all cases and 17.7%of all deaths are from people aged over 80 years,and cancer incidence and mortality in this age group showed upward trends for women.Lung cancer and digestive cancers are the leading cancer types for Chinese older people.Compared with other countries,China has lower incidence rates but higher mortality rates for older people.The rapidly growing burden of prostate cancer,breast cancer,colorectal cancer,and declines in esophageal cancer,stomach cancer,and liver cancer among older people indicate the cancer pattern in China is being in a transition stage to that in developed countries.Our findings imply that it should be the national health priority to meet the growing demands for cancer diagnosis,treatment and care services from the older people as the rapid population ageing in next few decades.

Global burden and trends of lung cancer incidence and mortality

Background:Lung cancer has been the leading cause of cancer-related deaths worldwide for many years.This study aimed to investigate the global patterns and trends of lung cancer.Methods:Lung cancer incidence and mortality were derived from the GLOBOCAN 2020 database.Continuous data from Cancer Incidence in Five Continents Time Trends were used to analyze the temporal trends from 2000 to 2012 using Joinpoint regression,and average annual percent changes were calculated.The association between the Human Development Index and lung cancer incidence and mortality was assessed by linear regression.Results:An estimated 2.2 million new lung cancer cases and 1.8 million lung cancer-related deaths occurred in 2020.The age-standardized incidence rate(ASIR)ranged from 36.8 per 100,000 in Demark to 5.9 per 100,000 in Mexico.The age-standardized mortality rate(ASMR)varied from 32.8 per 100,000 in Poland to 4.9 per 100,000 in Mexico.Both ASIR and ASMR were approximately twice higher in men than in women.The ASIR of lung cancer showed a downward trend in the United States of America(USA)between 2000 and 2012,and was more prominent in men.The age-specific incidence rates of lung cancer for ages of 50 to 59 years showed an upward trend in China for both men and women.Conclusions:The burden of lung cancer is still unsatisfactory,especially in developing countries like China.Considering the effectiveness of tobacco control and screening in developed countries,such as the USA,there is a need to strengthen health education,accelerate the establishment of tobacco control policies and regulations,and improve early cancer screening awareness to reduce the future burden of lung cancer.

Pediatric cancer surveillance in China:A hospital-based introduction

Background In recent years,increasing numbers of families have been affected by childhood cancer.According to data from the International Agency for Research on Cancer(IARC)of the World Health Organization,approximately 279000 new cases of cancer were predicted in children and adolescents aged 0–19 years worldwide in 2020.The global incidence of childhood cancer is 10.9 per 100000(global standard rate)and the mortality rate is 4.2 per 100000.1 According to data from the China National Cancer Center,the incidences of cancer in 2017 were 9.9 per 100000 in children aged 0–14 years and 11.5 per 100000 in adolescents aged 15–19 years.2 There are estimated to be approximately 22000 new cases of childhood cancer in China each year,and the incidence of malignant tumors in children aged 0–14 years has increased by 2.5%annually in the past decade.

中国人群伤残权重测量:聚焦癌症,量化评估伤残权重对癌症疾病负担估计的影响

伤残权重对于量化评估非死亡相关健康损失至关重要.全球范围看,目前仅有少数国家或地区对伤残权重进行了评估,且极少有肿瘤特异性的伤残权重结果报道.本研究基于大样本人群估计中国人群肿瘤特异性伤残权重,并比较不同伤残权重对量化评估肿瘤疾病负担的影响.基于开放式网络调查,采用配对比较的方法进行伤残权重的测量.伤残寿命损失年(YLDs)估计为不同瘤种各时期肿瘤的患病人数与其对应时期的伤残权重乘积之和.研究共收集到44,069份有效调查问卷,估计了包含18类恶性肿瘤在内的254个健康状态的残疾权重.其中,诊断和初始治疗阶段的肿瘤特异性伤残权差异较大,脑瘤的伤残权重最高为0.619(95%不确定性区间(UI):0.606~0.632),口咽癌伤残权重最低,为0.167(95%UI:0.158~0.176).不同肿瘤伤残权重对YLDs估计影响较大,所有肿瘤合计的YLDs差异超过30%.本研究提供的肿瘤特异性伤残权重可以为精确估计肿瘤疾病负担提供重要的数据支持.

Primary malignant bone tumors incidence,mortality,and trends in China from 2000 to 2015

Background:Primary malignant bone tumors are uncommon,and their epidemiological features are rarely reported.We aimed to study the incidence and death characteristics of bone tumors from 2000 to 2015.Methods:Population-based cancer registries submitted registry data to National Central Cancer Registry of China(NCCRC).The data collected from 501 local cancer registries in China were assessed using NCCRC screening methods and criteria.Incidence and mortality rates of primary bone tumor were stratified by age group,gender,and area.Age-standardized incidence and mortality rates were adjusted using the Chinese standard population in 2000 and Segi’s world population.The annual percentage change(APC)in rate was calculated using the Joinpoint Regression Program.Results:Data from 368 registries met quality control criteria,of which 134 and 234 were from urban and rural areas,respectively.The data covered 309,553,499 persons.The crude incidence,age-standardized incidence,and crude mortality rates were 1.77,1.35,and 1.31 per 100,000,respectively.Incidence and mortality rates were higher in males than those in females;they showed downward trends,with declines of 2.2%and 4.8%per year,respectively,and the rates in urban areas were lower than those in rural areas.Significant declining trends were observed in urban areas.Stable trends were seen in rural areas during 2000 to 2007,followed by downward trends.Age-specific incidence and mortality rates showed stable trends in the age group of 0 to 19 years,and downward trends in the age group elder than 19 years.Conclusions:The incidence and mortality rates of primary malignant bone tumors in rural areas were higher compared to those in urban areas.Targeted prevention measures are required to monitor and control bone tumor incidence and improve the quality of life of affected patients.This research can provide a scientific basis for the prevention and control of bone tumors,as well as basic information for follow-up research.